Trials / Unknown
UnknownNCT05292495
A Trial of HR17031 Injection With Renal Insufficiency
A Single-dose, Open Design Study to Evaluate The Pharmacokinetics of HR17031 Injection With Renal Insufficiency
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study used a single-dose, open design to compare the pharmacokinetics of subjects with mild, moderate and severe renal insufficiency and end-stage renal disease and subjects with normal renal function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HR17031 injection | HR17031 injection; administered subcutaneously. |
Timeline
- Start date
- 2022-03-31
- Primary completion
- 2022-12-15
- Completion
- 2022-12-30
- First posted
- 2022-03-23
- Last updated
- 2022-03-23
Source: ClinicalTrials.gov record NCT05292495. Inclusion in this directory is not an endorsement.